Dermatology Doctors in Bay Shore, NY Accepting Medicare

7 Dermatology doctors found. Showing 1 - 7

Dr. Julie Huh, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 332 E Main St, Bay Shore, NY 11706 Phone: 631-666-0500    Fax: 631-666-0503

Dr. Howard Corwin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2011 Union Blvd, Bay Shore, NY 11706 Phone: 631-666-2900    Fax: 631-666-2900

Neil Louis Bellet, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 53 Brentwood Rd, Suite D, Bay Shore, NY 11706 Phone: 631-665-0328    Fax: 631-665-0371

Dr. Jeffrey Bruce Pardes, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 332 E Main St, Bay Shore, NY 11706 Phone: 631-666-0500    Fax: 631-666-0503

Dr. Robert Alex Skrokov, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 332 E Main St, Bay Shore, NY 11706 Phone: 631-666-0500    Fax: 631-666-0503

Dr. Gavan David Moynihan, M.D Dermatology Medicare: Not Enrolled in Medicare Practice Location: 332 E Main St, Bay Shore, NY 11706 Phone: 631-666-0500    Fax: 631-666-0503

Dr. Robin B Septon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 332 E Main St, Bay Shore, NY 11706 Phone: 631-666-0500    Fax: 631-666-0503

News Archive

Tiniest pollution particles can contribute to cardiovascular disease in diabetic people

Scientists are untangling how the tiniest pollution particles - which we take in with every breath we breathe - affect our health, making people more vulnerable to cardiovascular and respiratory problems.

Teleflex announces launch of Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch® DispoLED™ Single-Use Fiber Optic Laryngoscope Handle — a cost-neutral way to combat cross-contamination infection risk during intubation.

Immunotherapy drug approved by FDA as first-line treatment for non-small cell lung cancer

Pembrolizumab, an immunotherapy drug that was extensively evaluated by UCLA cancer researcher Dr. Edward Garon, has been approved by the U.S. Food & Drug Administration as first-line treatment for non-small cell lung cancer (NSCLC).

GlobalPost blog interviews GAVI Board Chair about role of vaccines in ending preventable child deaths

At the Child Survival Call to Action summit in Washington, D.C. earlier this month, GlobalPost's "Global Pulse" blog spoke with Dagfinn Hoybraten - Norway's former health minister, current vice president of the Norwegian Parliament, and the Board chair of the GAVI Alliance - "about why he believes vaccines are essential to U.S. Secretary of State Hillary Clinton's goal of ending preventable child deaths."

Read more Medical News

› Verified 8 days ago